XML 10 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2024
Mar. 28, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description This Amendment No. 2 on Form 10-K/A (“Amendment”) is being filed to amend our Annual Report on Form 10-K (the “Annual Report”) for the fiscal year ended December 31, 2024 (the “Original Filing”), filed with the U.S. Securities and Exchange Commission on March 28, 2025 (the “Original Filing Date”). The sole purpose of this Amendment No. 1 is to include Exhibit 23.2 to the exhibits included in the Annual Report.  Except as described above, no changes have been made to the Original Filing and this Amendment No. 2 does not modify, amend or update in any way any of the financial or other information contained in the Original Filing. This Amendment No. 2 does not reflect events that may have occurred subsequent to the Original Filing Date.   In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by the Registrant’s principal executive officer and principal financial officer are filed herewith as exhibits to this Amendment pursuant to Rule 13a-14(a) and 15d-14(a) of the Exchange Act. The Registrant is not including certifications pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) as no financial statements are being filed with this Amendment.      
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --12-31    
Entity File Number 001-31361    
Entity Registrant Name MIRA Pharmaceuticals, Inc.    
Entity Central Index Key 0001904286    
Entity Tax Identification Number 85-3354547    
Entity Incorporation, State or Country Code FL    
Entity Address, Address Line One 1200 Brickell Avenue    
Entity Address, Address Line Two Suite 1950 #1183    
Entity Address, City or Town Miami    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33131    
City Area Code 786    
Local Phone Number 432-9792    
Title of 12(b) Security Common stock, par value $0.0001    
Trading Symbol MIRA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 2,440,211
Entity Common Stock, Shares Outstanding   16,813,654  
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Listing, Par Value Per Share $ 0.0001